What is the recommended dose of cefixime (a third-generation cephalosporin antibiotic) for a pediatric patient diagnosed with typhoid fever?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefixime Dosing for Typhoid Fever in Pediatric Patients

For pediatric patients with typhoid fever, administer cefixime at 8-10 mg/kg/day divided into two doses (every 12 hours) for 7-14 days, with the FDA-approved maximum daily dose of 8 mg/kg/day for general pediatric use, though higher doses (10-20 mg/kg/day) have been studied specifically for typhoid fever. 1, 2, 3

FDA-Approved Dosing Framework

The FDA label establishes the baseline pediatric dosing for cefixime:

  • Standard dose: 8 mg/kg/day administered as a single daily dose or divided into 4 mg/kg every 12 hours 1
  • Maximum daily dose for children ≥45 kg or >12 years: 400 mg (adult dose) 1
  • The suspension formulation is preferred for pediatric use and achieves higher peak blood levels than tablets 1

Typhoid Fever-Specific Dosing from Clinical Trials

Higher doses have been evaluated specifically for typhoid fever in children, with evidence supporting 10-20 mg/kg/day:

  • 10 mg/kg/day divided every 12 hours for 14 days was directly compared to ceftriaxone and showed equivalent efficacy (comparable defervescence times of ~8 days in both groups) 3
  • 20 mg/kg/day divided twice daily demonstrated 95% clinical cure rates in an 8-day short-course regimen for multidrug-resistant typhoid 2
  • A 7-day course at 20 mg/kg/day in two divided doses showed slower fever clearance (median 8.5 days) compared to ofloxacin but remained effective, with 75% cure rate 4

Treatment Duration Considerations

Duration should be 7-14 days based on clinical response and drug resistance patterns:

  • 14-day courses are more established and showed 90-93% cure rates in comparative trials 5, 3
  • 8-day short courses (20-30 mg/kg/day) demonstrated 95% efficacy for multidrug-resistant strains with only 1.7% relapse rate 2
  • 7-day courses are the minimum effective duration but may have higher failure rates (25% treatment failures with 20 mg/kg/day) 4

Practical Dosing Algorithm

For multidrug-resistant typhoid fever (most common scenario):

  1. Start with 10-15 mg/kg/day divided every 12 hours (balancing FDA guidance with typhoid-specific evidence) 1, 2, 3
  2. Plan for 10-14 days of therapy initially 2, 3
  3. If fever persists beyond 5-7 days, consider switching to alternative therapy (ceftriaxone or azithromycin) 3, 4

For drug-susceptible strains (rare):

  • Standard FDA dosing of 8 mg/kg/day may be adequate, but higher doses are reasonable given the severity of typhoid fever 1

Important Clinical Caveats

  • Cefixime shows slower fever clearance (median 8-9 days) compared to fluoroquinolones (4-5 days), so delayed defervescence does not necessarily indicate treatment failure 4
  • Monitor for treatment failure if fever persists beyond 10 days or clinical deterioration occurs; approximately 10-25% may require therapy change depending on resistance patterns 3, 4
  • Relapse rates are low (1.7-8%) but can occur up to 21 days post-therapy, requiring clinical follow-up 2, 3
  • Mild gastrointestinal side effects (nausea/vomiting 8%, loose stools 6%) are common but may be difficult to distinguish from typhoid symptoms 2
  • The suspension must specify concentration (100 mg/5 mL or 200 mg/5 mL) to avoid dosing errors 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.